LORD, ABBETT & CO. LLC - RAPTOR PHARMACEUTICAL CORP ownership

RAPTOR PHARMACEUTICAL CORP's ticker is RPTP and the CUSIP is 75382F106. A total of 71 filers reported holding RAPTOR PHARMACEUTICAL CORP in Q3 2013. The put-call ratio across all filers is 42.12 and the average weighting 0.1%.

Quarter-by-quarter ownership
LORD, ABBETT & CO. LLC ownership history of RAPTOR PHARMACEUTICAL CORP
ValueSharesWeighting
Q2 2014$8,886,000
+25.5%
769,354
+41.5%
0.01%
-37.5%
Q4 2013$7,080,000
-34.3%
543,775
-24.7%
0.02%
-36.0%
Q3 2013$10,784,000
+215.2%
721,849
+97.3%
0.02%
+212.5%
Q2 2013$3,421,000365,8850.01%
Other shareholders
RAPTOR PHARMACEUTICAL CORP shareholders Q3 2013
NameSharesValueWeighting ↓
Trellus Management Company, LLC 63,500$1,003,0001.13%
Broadfin Capital, LLC 1,319,883$20,841,0001.12%
BAILARD, INC. 160,000$2,526,0000.39%
Birchview Capital, LP 46,000$726,0000.38%
HIGHLAND CAPITAL MANAGEMENT LP 1,182,167$18,666,0000.38%
Rock Springs Capital Management LP 305,000$4,816,0000.35%
SPHERA FUNDS MANAGEMENT LTD. 206,500$3,261,0000.32%
GLOBEFLEX CAPITAL L P 109,771$1,733,0000.32%
GROUP ONE TRADING, L.P. 1,319,766$20,839,0000.29%
Perceptive Advisors 264,204$4,172,0000.25%
View complete list of RAPTOR PHARMACEUTICAL CORP shareholders